User profiles for David Coffey
David G. CoffeyUniversity of Miami Verified email at miami.edu Cited by 1691 |
Diagnosis and management of multiple myeloma: a review
Importance Multiple myeloma is a hematologic malignancy characterized by presence of
abnormal clonal plasma cells in the bone marrow, with potential for uncontrolled growth …
abnormal clonal plasma cells in the bone marrow, with potential for uncontrolled growth …
Mapping local photocurrents in polymer/fullerene solar cells with photoconductive atomic force microscopy
DC Coffey, OG Reid, DB Rodovsky… - Nano …, 2007 - ACS Publications
The performance of organic solar cells is highly dependent on film morphology. However,
directly correlating local film structures with device performance remains challenging. We …
directly correlating local film structures with device performance remains challenging. We …
Time-resolved electrostatic force microscopy of polymer solar cells
DC Coffey, DS Ginger - Nature materials, 2006 - nature.com
Blends of conjugated polymers with fullerenes, polymers, or nanocrystals make promising
materials for low-cost photovoltaic applications. Different processing conditions affect the …
materials for low-cost photovoltaic applications. Different processing conditions affect the …
MicroRNA-137 targets microphthalmia-associated transcription factor in melanoma cell lines
…, CM Amato, EH Classen, SE Robinson, DG Coffey… - Cancer research, 2008 - AACR
Micropthalmia-associated transcription factor (MITF) is the master regulator of melanocyte
development, survival, and function. Frequent alteration in the expression of MITF is detected …
development, survival, and function. Frequent alteration in the expression of MITF is detected …
Mathematical formulae for calculating the base temperature for growing degree days
S Yang, J Logan, DL Coffey - Agricultural and Forest Meteorology, 1995 - Elsevier
Much research has been done on finding methods to determine the base temperature, a very
important variable in computation of growing degree days (GDD). Four common methods …
important variable in computation of growing degree days (GDD). Four common methods …
An optimal driving force for converting excitons into free carriers in excitonic solar cells
DC Coffey, BW Larson, AW Hains… - The Journal of …, 2012 - ACS Publications
A general but limiting characteristic in excitonic photovoltaics is that a portion of the incident
photon energy appears necessary for converting excitons into electrical charges, resulting in …
photon energy appears necessary for converting excitons into electrical charges, resulting in …
Does antidepressant therapy improve cognition in elderly depressed patients?
…, T Oxman, LR Jenkyn, DJ Coffey… - The Journals of …, 2003 - academic.oup.com
Objectives. To analyze the effects of antidepressants on cognitive functioning in elderly
depression. Methods. Data were pooled for elderly participants with major depression from two …
depression. Methods. Data were pooled for elderly participants with major depression from two …
Fully human Bcma targeted chimeric antigen receptor T cells administered in a defined composition demonstrate potency at low doses in advanced stage high risk …
Background: Despite advances in the treatment of multiple myeloma (MM) almost all patients
relapse and high risk features continue to portend a short median survival. The adoptive …
relapse and high risk features continue to portend a short median survival. The adoptive …
[HTML][HTML] Origin and evolution of the T cell repertoire after posttransplantation cyclophosphamide
CG Kanakry, DG Coffey, AMH Towlerton, A Vulic… - JCI insight, 2016 - ncbi.nlm.nih.gov
Posttransplantation cyclophosphamide (PTCy) effectively prevents graft-versus-host
disease (GVHD), but its immunologic impact is poorly understood. We assessed lymphocyte …
disease (GVHD), but its immunologic impact is poorly understood. We assessed lymphocyte …
Genomic and immune signatures predict clinical outcome in newly diagnosed multiple myeloma treated with immunotherapy regimens
Despite improving outcomes, 40% of patients with newly diagnosed multiple myeloma treated
with regimens containing daratumumab, a CD38-targeted monoclonal antibody, progress …
with regimens containing daratumumab, a CD38-targeted monoclonal antibody, progress …